Academia
An article published in Experimental Biology and Medicine describes a new class of kinase inhibitors.
An article published in Experimental Biology and Medicine describes a new drug discovery model for mantle cell lymphoma, a deadly subtype of non-Hodgkin’s lymphoma.
Under the terms of the deal with Yale University, Yale researchers led by Geoff Chupp will conduct discovery research on targets associated with pulmonary diseases, then turn over the candidates to CureVac for preclinical and clinical development.
A new UK-based biotech company, AstronauTx Ltd, which builds on the work from the Alzheimer’s Research UK UCL Drug Discovery Institute (DDI), has received an investment of £6.5 million from the Dementia Discovery Fund (DDF).
More than three million citizens across the Leeds City Region are set to benefit as senior leaders from the healthtech industry, the regional enterprise partnership, the NHS, local authorities, and five universities announced a dynamic, new partnership to accelerate health technology innovation.
For 8-million adults who suffer from post-traumatic stress disorder in any given year, medication and cognitive therapy have been the treatment protocol.
Finding Could Lead to Better Clinical Disease Monitoring
Although anti-retroviral therapies have come a long way in turning HIV into being treated like a chronic, manageable disease, researchers are still attempting to find something that might be considered a cure, which would completely eradicate the virus. Researchers from University of Texas Medical Branch at Galveston may have found a way.
New ‘Vilnius-Made’ method reduces DNA testing costs by 90%, while the city’s long-standing tradition of life sciences further position Lithuanian Capital as emerging European hub of international scientific development
Device Also Can Serve as Robotic Skin, Relaying Information Back to the User
PRESS RELEASES